Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial.

Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 2004 Jul; 89(7):3319-25.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.